Related content

Efficacy of Bevacizumab in the First-Line Treatment of Patients with RAS Mutations Metastatic Colorectal Cancer: a Systematic Review and Network Meta-Analysis

By  

Cellular Physiology and Biochemistry, Vol. 40, Iss. 1-2, 2016-11 ,pp. : 361-369

Karger

Access to resources Recommend Favorite

Commitment of Scaffold Proteins in the Onco-Biology of Human Colorectal Cancer and Liver Metastases after Oxaliplatin-Based Chemotherapy

By Rotoli Deborah   Morales Manuel   Ávila Julio   Maeso María del Carmen   García María del Pino   Mobasheri Ali   Martín-Vasallo Pablo  

International Journal of Molecular Sciences, Vol. 18, Iss. 4, 2017-04 ,pp. : 891-891

MDPI

Access to resources Recommend Favorite

The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment

By de Vries Natasja L.   Swets Marloes   Vahrmeijer Alexander L.   Hokland Marianne   Kuppen Peter J. K.  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-06 ,pp. : 1030-1030

MDPI

Access to resources Recommend Favorite

Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment

By Bignucolo Alessia   De Mattia Elena   Cecchin Erika   Roncato Rossana   Toffoli Giuseppe  

International Journal of Molecular Sciences, Vol. 18, Iss. 7, 2017-07 ,pp. : 1522-1522

MDPI

Access to resources Recommend Favorite

Immune Checkpoints as a Target for Colorectal Cancer Treatment

By Passardi Alessandro   Canale Matteo   Valgiusti Martina   Ulivi Paola  

International Journal of Molecular Sciences, Vol. 18, Iss. 6, 2017-06 ,pp. : 1324-1324

MDPI

Access to resources Recommend Favorite